1. N. Bassil, S. Alkaade, J.E. Morley, The benefits and risks of testosterone replacement therapy: a review. Ther. Clin. Risk Manag. 5(3), 427–448 (2009).
2. P.J. Snyder, S. Bhasin, G.R. Cunningham, A.M. Matsumoto, A.J. Stephens-Shields, J.A. Cauley, T.M. Gill, E. Barrett-Connor, R.S. Swerdloff, C. Wang, K.E. Ensrud, C.E. Lewis, J.T. Farrar, D. Cella, R.C. Rosen, M. Pahor, J.P. Crandall, M.E. Molitch, D. Cifelli, D. Dougar, L. Fluharty, S.M. Resnick, T.W. Storer, S. Anton, S. Basaria, S.J. Diem, X. Hou, E.R. Mohler III, J.K. Parsons, N.K. Wenger, B. Zeldow, J.R. Landis, S.S. Ellenberg, Effects of testosterone treatment in older men. N. Engl. J. Med. 374(7), 611–624 (2016)
3. S. Basaria, A.S. Dobs, Hypogonadism and androgen replacement therapy in elderly men. Am. J. Med. 110(7), 563–572 (2001)
4. P.J. Snyder, H. Peachey, P. Hannoush, J.A. Berlin, L. Loh, J.H. Holmes, A. Dlewati, J. Staley, J. Santanna, S.C. Kapoor, M.F. Attie, J.G. Haddad Jr., B.L. Strom, Effect of testosterone treatment on bone mineral density in men over 65 years of age. J. Clin. Endocrinol. Metab. 84(6), 1966–1972 (1999)
5. J.A. Riancho, C. Sanudo, C. Valero, C. Pipaon, J.M. Olmos, V. Mijares, J.L. Fernandez-Luna, M.T. Zarrabeitia, Association of the aromatase gene alleles with BMD: epidemiological and functional evidence. J. Bone Miner. Res. 24(10), 1709–1718 (2009)